Zaki Hosny is a Senior Advisor at DGA-Albright Stonebridge Group, a founding member of DGA Group, and is based in Princeton. He supports the firm’s Health & Life Sciences practice, utilizing over three decades of experience in the international pharmaceutical industry to help clients achieve their strategic goals in overseas markets.

Prior to joining DGA-ASG, Mr. Hosny was Chief Executive Officer of Motif BioSciences Inc, a private genomics and drug discovery firm. Previously, he spent most of his career at Merck & Co in marketing & general management positions around the globe. Regional management positions included responsibility for the company’s business in its Mid-Europe Region, including Belgium, Netherlands, Austria, Portugal, Switzerland, Greece, Israel, South Africa and Scandinavia. In these positions, he gained a wealth of experience in diverse market access, pricing and reimbursement, regulatory, and government relations issues.

Mr. Hosny also held senior marketing roles with worldwide responsibility for cardiovascular and other franchises and was closely involved in the clinical development program for some of the company’s major products. Earlier in his career, he was a member of the European Government Affairs office and was closely involved in shaping the regulatory, pricing and patents legislation created under the EU single market program.

Mr. Hosny is a graduate of Cambridge University with an M.A. in history and law.